We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYZNW
14326
DELISTED
Hyzon Motors Inc. Warrants
HYZNW
$216 ﹤0.01%
45,895
-47,260
-51% -$808
IYZ icon
14327
iShares US Telecommunications ETF
IYZ
$1.24B
$215 ﹤0.01%
8
-40,674
-100% -$1.09M
SPRO icon
14328
CALL
Spero Therapeutics
SPRO
$71.8M
$206 ﹤0.01%
200
SPRO icon
14329
PUT
Spero Therapeutics
SPRO
$71.8M
$206 ﹤0.01%
200
IGC icon
14330
PUT
IGC Pharma
IGC
$30.7M
$202 ﹤0.01%
600
-600
-50% -$225
AWRE icon
14331
PUT
Aware
AWRE
$26M
$195 ﹤0.01%
100
-100
-50% -$171
OVID icon
14332
PUT
Ovid Therapeutics
OVID
$489M
$187 ﹤0.01%
200
-300
-60% -$336
STKH
14333
PUT
Steakholder Foods
STKH
$1.7M
$171 ﹤0.01%
1
-2
-67% -$578
TTT icon
14334
ProShares UltraPro Short 20+ Year Treasury
TTT
$18.3M
$160 ﹤0.01%
2
-3,173
-100% -$226K
RAPT
14335
DELISTED
RAPT Therapeutics
RAPT
$158 ﹤0.01%
+13
New +$165
XOSWW
14336
Xos Inc Warrants
XOSWW
$9.72K
$141 ﹤0.01%
27,090
-4,743
-15% -$69
FCUV icon
14337
PUT
Focus Universal
FCUV
$3.89M
$140 ﹤0.01%
1
-4
-80% -$409
FMS icon
14338
Fresenius Medical Care
FMS
$12.6B
$136 ﹤0.01%
6
-68,329
-100% -$1.48M
AFMD
14339
PUT
DELISTED
Affimed
AFMD
$119 ﹤0.01%
100
-800
-89% -$2.24K
BNCWW
14340
CEA Industries Inc Warrant
BNCWW
$118 ﹤0.01%
11,840
-800
-6% -$11
AIFU
14341
PUT
AIFU Inc
AIFU
$218M
0
GBIO
14342
PUT
DELISTED
Generation Bio
GBIO
$106 ﹤0.01%
+10
New +$178
UONEK icon
14343
PUT
Urban One Class D
UONEK
$24.1M
$100 ﹤0.01%
+10
New +$104
KRON
14344
PUT
DELISTED
Kronos Bio
KRON
$95 ﹤0.01%
100
CPTNW
14345
DELISTED
Cepton, Inc. Warrant
CPTNW
$88 ﹤0.01%
12,593
+600
+5% +$6
STLNW
14346
Starling Oncology, Inc. Warrant
STLNW
$5M
$87 ﹤0.01%
12,383
-5,425
-30% -$85
SONDW
14347
DELISTED
Sonder Holdings Inc Warrants
SONDW
$86 ﹤0.01%
14,363
-11,425
-44% -$118
OESX icon
14348
PUT
Orion Energy Systems
OESX
$84.2M
$80 ﹤0.01%
10
-920
-99% -$8.06K
DRIO icon
14349
PUT
DarioHealth
DRIO
$72.9M
$79 ﹤0.01%
5
-275
-98% -$4.76K
YI
14350
PUT
111 Inc
YI
$33.3M
$62 ﹤0.01%
10
-480
-98% -$3.74K

Similar funds

Citadel Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
  • Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.